Hematology最新文献

筛选
英文 中文
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively. CD7 CAR-T细胞特异性和有效地清除慢性髓系白血病干细胞。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-08-21 DOI: 10.1080/16078454.2026.2719241
Wenjing Zhang, Haobing Wang, Ling Tang, Yingjie Kong, Yong You, Xiaojian Zhu, Hongxiang Wang
{"title":"CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.","authors":"Wenjing Zhang, Haobing Wang, Ling Tang, Yingjie Kong, Yong You, Xiaojian Zhu, Hongxiang Wang","doi":"10.1080/16078454.2026.2719241","DOIUrl":"https://doi.org/10.1080/16078454.2026.2719241","url":null,"abstract":"<p><strong>Objectives: </strong>Leukemia stem cells (LSCs) in chronic myeloid leukemia (CML) are associated with disease recurrence and progression, cannot be eliminated by tyrosine kinase inhibitors (TKIs), and affect TKI discontinuation in CML patients. Chimeric antigen receptor T cells (CAR-T) therapy can eliminate tumor cells expressing specific antigens. CD7 is highly expressed on LSCs and can distinguish LSCs from normal hematopoietic stem cells (HSCs). This study explored the biological characteristics of CD7, and evaluated the effects of CD7 CAR-T cells on CD7<sup>+</sup> CML tumor cells and CD7<sup>+</sup> LSCs in vitro.</p><p><strong>Methods: </strong>We examined CD7 expression in primary CML LSCs, constructed CD7-overexpressing K562 cells, and assessed the in vitro cytotoxicity, degranulation and cytokine secretion of CD7 CAR-T cells against CD7<sup>+</sup> CML cells and CD34<sup>+</sup>CD7<sup>+</sup> LSCs, along with the correlation between CD7 and TKI resistance.</p><p><strong>Results: </strong>CD7<sup>+</sup> CML tumor cells were resistant to TKI to a certain extent. This molecule appears to be relevant to the survival of LSCs in patients with CML receiving TKI-targeted therapy. In the in vitro co-culture system, CD7 CAR-T cells effectively eliminate CD7<sup>+</sup> CML cells and LSCs and exhibit multiple immunological activities during the co-culture process.</p><p><strong>Discussion: </strong>This study targets the key limitation of current CML treatment in that TKIs fail to eliminate LSCs, and confirms the correlation between CD7 and LSC survival, as well as the targeting potential of CD7 CAR-T for CML.</p><p><strong>Conclusion: </strong>This study showed that using CD7 CAR-T cells to specifically eliminate LSCs is effective and rational in vitro, which provides experimental evidence for LSC-targeted CML therapy and lays a foundation for subsequent in vivo and translational research.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2719241"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148792389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and internal validation of a machine learning model for predicting second primary malignancy risk in hodgkin lymphoma survivors: a population-based competing risk analysis. 用于预测霍奇金淋巴瘤幸存者第二原发性恶性肿瘤风险的机器学习模型的开发和内部验证:基于人群的竞争风险分析。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-09-28 DOI: 10.1080/16078454.2026.2737562
Sinian Li, Mingyue Xiong, Zhonggui Gan, Haishan Lu, Yiheng Zhao, Hong Huang, Tingzhuang Yi
{"title":"Development and internal validation of a machine learning model for predicting second primary malignancy risk in hodgkin lymphoma survivors: a population-based competing risk analysis.","authors":"Sinian Li, Mingyue Xiong, Zhonggui Gan, Haishan Lu, Yiheng Zhao, Hong Huang, Tingzhuang Yi","doi":"10.1080/16078454.2026.2737562","DOIUrl":"https://doi.org/10.1080/16078454.2026.2737562","url":null,"abstract":"<p><strong>Background: </strong>Hodgkin lymphoma (HL) survivors face an elevated long-term risk of developing second primary malignancies (SPMs), yet accurate prediction tools remain scarce. This study aimed to develop and internally validate a machine learning-based prediction model for SPM risk in HL survivors using a competing risk framework.</p><p><strong>Methods: </strong>We analysed 57,429 patients diagnosed with HL between 2006 and 2020 from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly divided into training (<i>n</i> = 40,201, 70%) and internal validation (<i>n</i> = 17,228, 30%) cohorts. A random survival forest (RSF) model was developed to predict SPM occurrence, with death without SPM treated as a competing event. Model performance was compared against the traditional Fine-Grey subdistribution hazard regression. Discrimination was assessed using time-dependent area under the receiver operating characteristic curve (AUC), and calibration was evaluated through calibration plots. Clinical utility was determined via decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) analysis was employed to interpret the model.</p><p><strong>Results: </strong>During follow-up, 4,954 patients (8.6%) developed SPMs, while 9,750 (17.0%) died without SPM. The RSF model demonstrated superior discriminative ability compared to Fine-Grey regression across all time points: AUC at 3 years (0.721 vs. 0.549), 5 years (0.761 vs. 0.555), and 10 years (0.804 vs. 0.553). Calibration plots indicated good agreement between predicted and observed risks. DCA confirmed the RSF model provided greater net clinical benefit across a wide range of threshold probabilities. SHAP analysis identified age as the most influential predictor, followed by disease stage, radiotherapy status, race, sex, and chemotherapy.</p><p><strong>Conclusions: </strong>The RSF-based machine learning model accurately predicts SPM risk in HL survivors within a competing risk framework, substantially outperforming traditional regression approaches. This interpretable prediction tool may facilitate personalised surveillance strategies and risk-adapted follow-up for HL survivors.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2737562"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding multiple myeloma: insights into patients' experiences and preferences for communication, information and support. 了解多发性骨髓瘤:洞察患者的经历和对沟通、信息和支持的偏好。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-11-12 DOI: 10.1080/16078454.2026.2762576
Helena Harder, Rachel Hunter, Barbara Collinson, John Jones, Theresa Street, Clare Evans, Anna Cowley, Val Jenkins
{"title":"Understanding multiple myeloma: insights into patients' experiences and preferences for communication, information and support.","authors":"Helena Harder, Rachel Hunter, Barbara Collinson, John Jones, Theresa Street, Clare Evans, Anna Cowley, Val Jenkins","doi":"10.1080/16078454.2026.2762576","DOIUrl":"https://doi.org/10.1080/16078454.2026.2762576","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the unmet communication, information, and support needs of people living with multiple myeloma (MM) and identify helpful and unhelpful phrases or behaviors used by family and friends (F&F) and healthcare professionals (HCPs) in the Patient Understanding of Multiple Myeloma and Communication Experiences (PUMMaCE) study.</p><p><strong>Methods: </strong>An online survey was co-developed with HCPs and people living with MM, as part of the study. The survey consisted of closed- and open-ended questions. A framework analysis was conducted on the qualitative free-text responses to identify key themes related to patients' communication experiences and preferences.</p><p><strong>Results: </strong>In total, 138 people living with MM completed the survey. The free-text comments were organized into six overarching themes. Making sense of MM, gaps in understanding MM, communicating MM to F&F, F&F behaviors, HCP interactions, and healthcare systems and pathways. Many felt confused by the complex terminology and had unanswered questions about their disease, treatment, and prognosis. Limited understanding often led to F&F exhibiting unhelpful behaviors. Yet, there were also examples of positive communication and behaviors that supported respondents in managing their day-to-day life.</p><p><strong>Discussion and conclusion: </strong>Significant gaps in communication, information, and support exist in MM care. The findings of this survey illustrate the challenges posed by the complexity of the language used routinely by HCPs, which can lead to distress and misunderstandings. These data will be used to inform the production of educational materials to improve communication among patients, their families, and HCPs.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2762576"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149405232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between household pesticide exposure and anemia is modified by dietary selenium intake: a population-based study. 家庭农药暴露与贫血之间的关系被膳食硒摄入量所改变:一项基于人群的研究。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-04-14 DOI: 10.1080/16078454.2026.2659975
Jinhui Gan, Qing Xie, Xiaoqin Xin
{"title":"The association between household pesticide exposure and anemia is modified by dietary selenium intake: a population-based study.","authors":"Jinhui Gan, Qing Xie, Xiaoqin Xin","doi":"10.1080/16078454.2026.2659975","DOIUrl":"10.1080/16078454.2026.2659975","url":null,"abstract":"<p><strong>Background: </strong>While the detrimental health effects of occupational pesticide exposure are well-documented, the association between household pesticide use and anemia in the general adult population remains underexplored. Furthermore, the potential for dietary factors, such as selenium, to modulate this relationship is unknown.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis using data from 14,708 adults (≥18 years) who participated in the National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018. Household pesticide exposure was self-reported. Anemia was defined according to World Health Organization criteria (hemoglobin <13 g/dL for men, <12 g/dL for women). Dietary selenium intake was categorized as low (<125 µg/day) or high (≥125 µg/day). Multivariable logistic regression models were used to evaluate the association between pesticide exposure and anemia. The modifying effect of selenium was assessed using an interaction term and stratified analyses.</p><p><strong>Results: </strong>Of the 14,447 participants included in the final analysis, 1,516 (10.5%) reported household pesticide exposure, and 1,506 (10.4%) met the criteria for anemia. Household pesticide exposure was associated with higher odds of anemia (OR = 1.23; 95% CI: 1.03-1.47). A significant interaction with selenium intake was observed (<i>p</i> = 0.032). Among participants with low selenium intake, pesticide exposure increased anemia risk (OR = 1.31; 95% CI: 1.06-1.61), whereas no association was found in the high selenium group (OR = 0.74; 95% CI: 0.49-1.11).</p><p><strong>Conclusion: </strong>This study provides novel evidence that household pesticide exposure is associated with a modestly increased prevalence of anemia in the general U.S. adult population. Furthermore, our findings suggest that adequate dietary selenium intake may mitigate this hematological risk.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2659975"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147689876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First report of a rare hemoglobin variant in the Chinese population: clinical and hematological characteristics of Hb Norton [HBA2:c.217C>G] and its impact on HbA1c testing: a case report. 中国人群中一种罕见血红蛋白变异的首次报道:诺顿血红蛋白的临床和血液学特征[HBA2:c]。[17]及其对HbA1c检测的影响:1例报告。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-04-27 DOI: 10.1080/16078454.2026.2665490
Jian Shang, Zirui Cao, Weidong Chen, Huijun Yang
{"title":"First report of a rare hemoglobin variant in the Chinese population: clinical and hematological characteristics of Hb Norton [HBA2:c.217C>G] and its impact on HbA1c testing: a case report.","authors":"Jian Shang, Zirui Cao, Weidong Chen, Huijun Yang","doi":"10.1080/16078454.2026.2665490","DOIUrl":"10.1080/16078454.2026.2665490","url":null,"abstract":"<p><strong>Objectives: </strong>Hemoglobin (Hb) variants are a common type of single-gene disorder and a frequent source of interference in HbA<sub>1c</sub> testing. Here, we first report a rare Hb variant, Hb Norton [HBA2:c.217C>G], in the Chinese population.</p><p><strong>Methods and results: </strong>A 38-year-old man presented with a normal clinical and hematological phenotype. He was suspected of carrying an Hb variant following an HbA<sub>1c</sub> measurement using a high-performance liquid chromatography (HPLC) method (Bio-Rad D100), which resulted in an extremely high value of 20.24%. HbA<sub>1c</sub> was reanalyzed using a capillary electrophoresis (CE) method (Capillarys3 TERA) and a boronate affinity HPLC system (Premier Hb9210), and the results were 5.49% and 5.60%, respectively. Hemoglobin analysis by CE and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) revealed a variant peak with a mass-to-charge ratio (m/z) = 10105 Da. Sanger sequencing confirmed the presence of a rare Hb variant, Hb Norton [HBA2:c.217C>G]. It was conclusively confirmed that the co-elution of Hb Norton and HbA<sub>1c</sub> components led to the falsely elevated HbA<sub>1c</sub> values.</p><p><strong>Conclusions: </strong>Some rare variants can severely affect HbA<sub>1c</sub> analysis. When encountering abnormally high values that are difficult to explain, one should consider whether variant interference is present.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2665490"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147769954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune reconstitution and viral reactivation after allogeneic hematopoietic stem cell transplantation in hematologic malignancies. 异体造血干细胞移植治疗恶性血液病后的免疫重建和病毒再激活。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-07-31 DOI: 10.1080/16078454.2026.2707676
Muhammad Qaiser, Hao Zhou, Guangyu Zhou, Guilin Ren, Xi Dou, Xin Wang, Xiaoqiong Tang, Xiaohua Luo, Hongbin Zhang, Asad Nawaz, Jianbin Chen, Lin Liu, Muhammad Junaid Akram, Li Wang
{"title":"Immune reconstitution and viral reactivation after allogeneic hematopoietic stem cell transplantation in hematologic malignancies.","authors":"Muhammad Qaiser, Hao Zhou, Guangyu Zhou, Guilin Ren, Xi Dou, Xin Wang, Xiaoqiong Tang, Xiaohua Luo, Hongbin Zhang, Asad Nawaz, Jianbin Chen, Lin Liu, Muhammad Junaid Akram, Li Wang","doi":"10.1080/16078454.2026.2707676","DOIUrl":"10.1080/16078454.2026.2707676","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate associations between post-transplant immune reconstitution, Epstein-Barr virus (EBV) and cytomegalovirus (CMV) DNAemia/reactivation, and survival after allogeneic hematopoietic stem cell transplantation (HSCT).</p><p><strong>Methods: </strong>We conducted a retrospective observational cohort study of 312 patients with hematologic malignancies who underwent allogeneic HSCT between 2016 and 2024. Bone marrow B-cell proportion and peripheral blood lymphocyte subsets were assessed longitudinally by flow cytometry. EBV and CMV reactivation was monitored by quantitative PCR and analyzed as surveillance-defined reactivation status. Landmark-based logistic regression evaluated associations between immune-reconstitution parameters and viral reactivation; receiver operating characteristic analysis assessed model discrimination, and Cox regression evaluated overall survival determinants.</p><p><strong>Results: </strong>CMV and EBV DNAemia/reactivation occurred in 42.0% and 31.4% of patients, respectively, and were significantly correlated (<i>ρ</i> = 0.191, <i>p</i> = 0.028). Higher bone marrow B-cell proportion at sixmonths was associated with lower odds of CMV DNAemia/reactivation (OR = 0.947, 95% CI: 0.901-0.995, <i>p</i> = 0.034). For EBV, an exploratory interaction between 12-month CD8⁺ T-cell recovery and chronic GVHD was associated with EBV DNAemia/reactivation status (<i>p</i> = 0.039). Lower NK-cell levels were observed in patients with EBV and CMV coinfection (<i>p</i> = 0.021 and <i>p</i> = 0.036, respectively). Overall survival was mainly associated with relapse (HR = 5.5, <i>p</i>0.001) and conditioning regimen, whereas viral reactivation was not significantly associated with survival.</p><p><strong>Discussion: </strong>Intermediate immune-reconstitution landmarks showed distinct associations with surveillance-defined viral reactivation, particularly six-month B-cell proportion for CMV and CD8⁺ T-cell recovery in the context of chronic GVHD for EBV.</p><p><strong>Conclusion: </strong>Longitudinal immune-reconstitution patterns may help characterize persistent post-HSCT immune vulnerability, although prospective studies incorporating viral timing and treatment-exposure data are needed for validation.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2707676"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148630327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and genetic features of Ph-negative myeloproliferative neoplasms with dual-driver gene positivity. 双驱动基因阳性的ph阴性骨髓增殖性肿瘤的临床和遗传学特征。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-09-01 DOI: 10.1080/16078454.2026.2717810
Yan Yang, Qunyi Guo, Tao-Hsin Tung, Jia Zhang, Yuanwen Wang, Shuangwei Ying
{"title":"Clinical and genetic features of Ph-negative myeloproliferative neoplasms with dual-driver gene positivity.","authors":"Yan Yang, Qunyi Guo, Tao-Hsin Tung, Jia Zhang, Yuanwen Wang, Shuangwei Ying","doi":"10.1080/16078454.2026.2717810","DOIUrl":"https://doi.org/10.1080/16078454.2026.2717810","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the clinical laboratory characteristics and gene mutation features of dual-driver gene positivity in patients with Philadelphia chromosome-negative myeloproliferative neoplasm (Ph-negative MPN).</p><p><strong>Methods: </strong>We conducted a retrospective analysis of clinical data and genetic test results from 203 newly diagnosed patients with Ph-negative MPN. Of these, 194 had single-driver gene positivity and 9 had dual-driver gene positivity. High-throughput sequencing was used to detect mutations in <i>JAK2</i>, <i>CALR</i>, and <i>MPL</i>. Clinical characteristics and gene mutation profiles were compared between the two patient groups.</p><p><strong>Results: </strong>The incidence of dual-driver gene positivity was 4.4% (9/203), with the most common combinations being <i>JAK2</i> with <i>CALR</i> (4 patients) and <i>JAK2</i> with <i>MPL</i> (4 patients). Compared with the single-driver group, the dual-driver group had a significantly higher risk of bleeding [4.1% (8/194) vs. 33.3% (3/9), <i>P</i> = 0.008] and a higher proportion of uncommon mutations [3.6% (7/194) vs. 33.3% (3/9), <i>P</i> = 0.006]. No statistically significant differences were observed between the two groups regarding age, thrombosis incidence, splenomegaly, or routine blood test indicators. During follow-up, 1 patient in the dual-driver group died from cerebrovascular disease. No leukaemia transformation or disease-related deaths occurred among the remaining patients.</p><p><strong>Discussion: </strong>The increased bleeding risk in dual-driver patients may be related to a higher proportion of <i>CALR</i> mutations, elevated platelet counts, and higher variant allele frequencies, though these findings require validation in larger cohorts due to the small sample size. The higher prevalence of uncommon mutations suggests a more complex mutational landscape in this subgroup.</p><p><strong>Conclusion: </strong>Patients with Ph-negative MPN and dual-driver gene positivity may have a higher risk of bleeding and a more complex gene mutation profile.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2717810"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148873874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
miR-877-5P acts as a tumor suppressor in multiple myeloma by targeting MAPK8: a study on prognostic value and functional mechanism. miR-877-5P通过靶向MAPK8在多发性骨髓瘤中发挥抑瘤作用:预后价值及功能机制研究
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-09-24 DOI: 10.1080/16078454.2026.2722564
Zhimin Bai, Qiulian Luo, Shasha Zhao
{"title":"miR-877-5P acts as a tumor suppressor in multiple myeloma by targeting MAPK8: a study on prognostic value and functional mechanism.","authors":"Zhimin Bai, Qiulian Luo, Shasha Zhao","doi":"10.1080/16078454.2026.2722564","DOIUrl":"https://doi.org/10.1080/16078454.2026.2722564","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate Investigate the expression level, prognostic value, and biological function of miR-877-5p in MM.</p><p><strong>Methods: </strong>A total of 103 MM patients and 98 non-tumor controls were included in the study. miR-877-5p expression level was verified by RT-qPCR, and its prognostic value was evaluated through Kaplan-Meier and the Cox regression model. MM cell proliferation and apoptosis were assessed with the CCK‑8 assay and flow cytometry. The potential target genes of miR-877-5p were predicted by bioinformatics analysis and verified by dual luciferase assay. Rescue assays confirmed that MAPK8 mediates the regulatory function of miR-877-5p.</p><p><strong>Results: </strong>miR-877-5p was reduced in MM, and its low level was associated with a poorer overall survival of patients, being an independent prognosticator of poor survival in MM. Function experiments confirmed that overexpression of miR-877-5p could inhibit the proliferation of MM cells and promote apoptosis. Mechanistically, MAPK8 was a direct downstream target of miR-877-5p. MAPK8 was upregulated in MM and negatively correlated with miR-877-5p levels. Rescue assays were conducted to verify that MAPK8 overexpression reversed the effect of miR-877-5p on MM cell proliferation and apoptosis.</p><p><strong>Discussion: </strong>These findings indicate that miR-877-5p exerts tumor-suppressive functions in MM, likely through negative regulation of MAPK8. The miR-877-5p/MAPK8 axis may represent a novel regulatory pathway involved in MM progression.</p><p><strong>Conclusions: </strong>miR-877-5p acts as a tumor suppressor in MM and may serve as a potential biomarker for prognosis assessment. Its regulatory role in MM progression is likely mediated through targeting and inhibiting MAPK8.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2722564"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monoclonal gammopathy of clinical significance: the pathogenic paraprotein and a precision medicine roadmap. 临床意义的单克隆伽玛病:致病副蛋白和精准医学路线图。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-11-09 DOI: 10.1080/16078454.2026.2755113
Hamed Soleimani Samarkhazan, Forouzan Bahmani, Mohammad Rayati, Zahra Taheri Zare, Reza Emadi, Zahra Shirgholami, Mohammad Hossein Mohammadi
{"title":"Monoclonal gammopathy of clinical significance: the pathogenic paraprotein and a precision medicine roadmap.","authors":"Hamed Soleimani Samarkhazan, Forouzan Bahmani, Mohammad Rayati, Zahra Taheri Zare, Reza Emadi, Zahra Shirgholami, Mohammad Hossein Mohammadi","doi":"10.1080/16078454.2026.2755113","DOIUrl":"https://doi.org/10.1080/16078454.2026.2755113","url":null,"abstract":"<p><strong>Introduction: </strong>Monoclonal Gammopathy of Clinical Significance (MGCS) challenges the traditional binary classification of plasma cell disorders as either benign or malignant. MGCS is defined by a small B-cell or plasma cell clone that does not meet criteria for malignancy yet secretes a pathogenic paraprotein causing significant end-organ damage.</p><p><strong>Objectives: </strong>This review aims to decode the mechanisms of paraprotein-mediated organ injury, chart the diverse clinical spectrum of MGCS, integrate modern diagnostic approaches, and propose a precision medicine roadmap for targeted therapeutic intervention.</p><p><strong>Methods: </strong>We performed a structured narrative review. PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library were searched from inception to 30 September 2026 using terms for MGCS, MGUS, MGRS, MGNS, AL amyloidosis, paraprotein, and clone-directed therapy. Two reviewers independently screened titles/abstracts and full texts; peer-reviewed original studies, guidelines, consensus reports, and selected case series/reports were included. Data on pathophysiology, clinical phenotype, diagnosis, treatment, and outcomes were extracted. Study quality was appraised using design-specific domains (risk of bias, sample size, diagnostic ascertainment, confounding, follow-up, statistical reporting, and directness); because of heterogeneity, no meta-analysis was performed, and evidence was synthesized narratively with qualitative certainty ratings.</p><p><strong>Results: </strong>The pathogenic mechanisms extend beyond simple deposition to include autoantibody mimicry and direct cellular toxicity. MGCS manifests as a master of disguise, with organ involvement including cardiac amyloidosis, renal dysfunction (MGRS), peripheral neuropathies (MGNS), and dermatologic conditions. Diagnostic advances incorporating mass spectrometry and serum free light chain assays have enhanced sensitivity over traditional electrophoresis. Management requires a paradigm shift from empiric immunosuppression to clone-directed therapies, including anti-CD20 agents, proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, and emerging BCMA-targeting therapies, tailored to immunoglobulin isotype, pathogenic mechanism, and patient frailty.</p><p><strong>Discussion: </strong>Persistent challenges include the absence of early biomarkers, lack of validated MGCS-specific response criteria, and the need for therapies targeting both the clone and toxic paraprotein directly. Multidisciplinary collaboration and integration of multi-omics with artificial intelligence hold promise for improved risk stratification.</p><p><strong>Conclusion: </strong>Conquering MGCS requires increased recognition, early diagnosis, and targeted intervention to prevent irreversible organ injury and improve patient outcomes.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2755113"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression. 雷洛昔芬通过靶向ANP32B基因,调控C-MYC表达抑制小儿急性髓系白血病的增殖。
IF 2 4区 医学
Hematology Pub Date : 2026-12-31 Epub Date: 2026-06-29 DOI: 10.1080/16078454.2026.2691533
Xiaomei Wan, Zhong Yu, Chengcheng Huang, Ying Ren
{"title":"Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression.","authors":"Xiaomei Wan, Zhong Yu, Chengcheng Huang, Ying Ren","doi":"10.1080/16078454.2026.2691533","DOIUrl":"https://doi.org/10.1080/16078454.2026.2691533","url":null,"abstract":"<p><strong>Objective: </strong>Acute myeloid leukemia (AML) is a severe and life-threatening malignant disease of the hematopoietic system. Our previous research found that ANP32B is regulated by super enhancers in pediatric AML and regulates the progression of AML by modulating histone H3K27ac. Using virtual screening technology, we discovered that Raloxifene may be a small-molecule inhibitor targeting ANP32B.</p><p><strong>Methods: </strong>Proliferation and apoptosis analysis were used to evaluate the effect of Raloxifene on AML cells. By establishing a xenograft model in NSG mice, 10.0 mg/kg of Raloxifene or a control solvent was intraperitoneally injected into the mice daily, and the tumor progression was monitored. Additionally, RNA sequencing, qRT‒PCR and WB were used to measure gene expression levels after Raloxifene treatment.</p><p><strong>Results: </strong>The CCK-8 assay showed the IC50 value of Raloxifene in AML cells. The number and size of colony-forming AML cells treated with Raloxifene significantly decreased, and cell apoptosis increased in a dose-dependent manner. The fluorescence values in NSG mice treated with Raloxifene was significantly lower than control group. RNA sequencing revealed that Raloxifene inhibited the expression of the MYC pathway genes in MV4-11 cells.</p><p><strong>Conclusion: </strong>Raloxifene exhibits anti-AML activity both in vitro and in vivo. By targeting ANP32B, Raloxifene effectively inhibits the proliferation of AML cells, induces cell apoptosis, and reduces the expression of C-MYC. Raloxifene may potentially serve as a candidate drug for the treatment of acute myeloid leukemia.</p>","PeriodicalId":13161,"journal":{"name":"Hematology","volume":"31 1","pages":"2691533"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148351932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书